Oryzon Genomics SA (ORY) — Free Cash Flow Generation Index

Latest as of December 2015: 1.17x

Oryzon Genomics SA (ORY) has a Free Cash Flow Generation Index of 1.17x as of December 2015. Free cash flow of €610.80K represents 1% of operating cash flow (€523.10K). Explore Oryzon Genomics SA capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

1.17x
Free Cash Flow / Operating CF

Free Cash Flow

€610.80K
EUR

Operating Cash Flow

€523.10K
EUR

Capital Expenditures

€87.70K
EUR

Oryzon Genomics SA Free Cash Flow Generation Index (2013–2015)

Historical FCF Generation Index trend for Oryzon Genomics SA across 3 annual periods. For the full cash flow conversion analysis, see Oryzon Genomics SA (ORY) cash conversion ratio.

Annual Free Cash Flow Generation for Oryzon Genomics SA (2013–2015)

Year-by-year Free Cash Flow Generation Index for Oryzon Genomics SA. Check ORY cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (EUR) Operating CF Capital Expenditures YoY Change
2015 1.17x €610.79K €523.14K €87.65K ▲ +16.3%
2014 1.00x €12.17 Million €12.13 Million €47.00K ▼ 0.0%
2013 1.00x €12.17 Million €12.13 Million €47.30K
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).